LynnMarieMalecMD

PubMed

• 4 citations
  Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database.
  Jonathan C. Roberts, Lynn M. Malec, Imrran Halari, Sarah A Hale, Abiola Oladapo, Robert F. Sidonio> ;Haemophilia. 2021 Nov 10
• 6 citations
  Hemophilia B (Factor IX Deficiency).
  Robert F. Sidonio, Lynn M. Malec> ;Hematology/oncology Clinics of North America. 2021 Oct 1
• 17 citations
  The Impact of Extended Half‐Life Factor Concentrates on Prophylaxis for Severe Hemophilia in The United States
  Lynn M. Malec, Dunlei Cheng, Char Witmer, Julie Jaffray, Peter A. Kouides, Kristina M. Haley, Robert F. Sidonio, Kelsey Johnson, Michael Recht, Gilbert C. White, Stacy...> ;American Journal of Hematology. 2020 Aug 1
• 5 citations
  Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A.
  Patrick T. Ebbert, Frederico Xavier, Lynn M. Malec, Craig D. Seaman, Margaret V. Ragni> ;Thrombosis Research. 2020 Nov 1
• Case 3: Cytopenias and Myelopathy in a 15-year-old Boy with Autism.
  Amita Ghuman, Allison Close, Lynn M. Malec> ;Pediatrics in Review. 2020 Jul 1
• 1 citations
  The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive value.
  Lynn M. Malec, Mark Crowther> ;European Journal of Internal Medicine. 2020 Jun 7
• 19 citations
  Spontaneous bleeding and poor bleeding response with extended half-life factor IX products: A survey of select US haemophilia treatment centres.
  Lynn M. Malec, Stacy E. Croteau, Michael U. Callaghan, Robert F. Sidonio> ;Haemophilia. 2020 Mar 6
• Nonimmune Anemias.
  Lynn Malec> ;Clinics in Perinatology. 2020 Mar 1
• 31 citations
  Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and s...
  Stacy E. Croteau, Dunlei Cheng, Alice J. Cohen, Chris E. Holmes, Lynn M. Malec, Michael Silvey, Courtney D. Thornburg, Allison P. Wheeler, Peter A. Kouides, Leslie Raf...> ;Haemophilia. 2019 Jul 1
• 6 citations
  rFIXFc for Immune Tolerance Induction in a Severe Hemophilia B Patient with an Inhibitor and Prior History of ITI Related Nephrotic Syndrome.
  Lynn M. Malec, Thomas C. Abshire, Shawn M. Jobe, Gilbert C. White> ;Haemophilia. 2018 Jul 1
• 6 citations
  Prophylactic rtPA in the Prevention of Line-associated Thrombosis and Infection in Short Bowel Syndrome.
  Lynn M. Malec, James D. Cooper, Jeffrey A. Rudolph, Marian G. Michaels, Margaret V. Ragni> ;Journal of Pediatric Gastroenterology and Nutrition. 2017 Nov 1
• 33 citations
  Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.
  Christine M. Leeper, Madhav Vissa, James D. Cooper, Lynn M. Malec, Barbara A. Gaines> ;Pediatric Blood & Cancer. 2017 Aug 1
• 8 citations
  Feasibility of the Von Willebrand disease PREVENT trial.
  Margaret V. Ragni, Nicoletta Machin, Andra H. James, Craig D. Seaman, Lynn M. Malec, Craig M. Kessler, Barbara A. Konkle, Peter A. Kouides, Anne T. Neff, Claire S. Phi...> ;Thrombosis Research. 2017 Aug 1
• 26 citations
  Treatment of Venous Thromboembolism in Pediatric Patients
  Lynn M. Malec, Guy Young> ;Frontiers in Pediatrics. 2017 Feb 28
• 23 citations
  Extended half‐life factor VIII for immune tolerance induction in haemophilia
  Lynn M. Malec, Janna M. Journeycake, Margaret V. Ragni> ;Haemophilia. 2016 Nov 1
• 8 citations
  Inhibitor development in two cousins receiving full-length factor VIII (FVIII) and FVIII-Fc fusion protein.
  Margaret V. Ragni, M. Alabek, Lynn M. Malec> ;Haemophilia. 2016 Sep 1
• 23 citations
  Von Willebrand factor for menorrhagia: a survey and literature review.
  Margaret V. Ragni, Nicoletta Machin, Lynn M. Malec, Andra H. James, Craig M. Kessler, B. A. Konkle, Peter A. Kouides, Anne T. Neff, Claire S. Philipp, Donald Brambilla> ;Haemophilia. 2016 Feb 4
• 3 citations
  Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction
  Margaret V. Ragni, Donna DiMichele, C. M. Hay, Lynn M. Malec, Craig D. Seaman, Jie Li, Jonathan G. Yabes, Saulius Butenas, Kathleen E. Brummel-Ziedins> ;Haemophilia. 2016 Mar 1
• 10 citations
  Validation Study of the Composite Score to Identify Von Willebrand Disease in Children.
  Lynn M. Malec, Charity G. Moore, Carolyn M. Bennett, Donald L. Yee, Bryce A. Kerlin, Char Witmer, Roshni Kulkarni, Sweta Gupta, Sriya Gunawardena, Peter A. Kouides, De...> ;Journal of Pediatric Hematology/oncology. 2016 Mar 1
• 12 citations
  Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database
  Lynn M. Malec, Charity G. Moore, Jonathan G. Yabes, Jie Li, Margaret V. Ragni> ;Haemophilia. 2015 Sep 1
• 16 citations
  Design of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting tolerance.
  Margaret V. Ragni, Lynn M. Malec> ;Expert Review of Hematology. 2014 Nov 11
• 5 citations
  Three cost-utility analyses of screening for intracranial hemorrhage in neonates with hemophilia.
  Lynn M. Malec, Robert F. Sidonio, Kenneth J. Smith, James D. Cooper> ;Journal of Pediatric Hematology/oncology. 2014 Aug 1
• Join now to see all

Abstracts/Posters

• Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
  Lynn M. Malec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database
  Lynn M Malec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019